malondialdehyde has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrettini, M; De Cunto, M; Grasselli, S; Nenci, GG; Parise, P | 1 |
| Feller, DR; Kim, SU; Newman, HA; Romstedt, KJ; Witiak, DT | 1 |
| Anwer, K; Gabis, J; Gojer, C; Romstedt, K | 1 |
| Barbieri, B; Bertelé, V; Bianchi, L; Cerletti, C; de Gaetano, G; Dejana, E; di Minno, G; Silver, MJ | 1 |
| Conti, CR; Mehta, J; Mehta, P | 1 |
| Guengerich, FP; Marnett, LJ; Nebert, DW; Plastaras, JP | 1 |
6 other study(ies) available for malondialdehyde and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
"In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Male; Malondialdehyde; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase | 1990 |
Potent antiplatelet effects of cyclic clofibric acid (CPIB) analogs on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Benzopyrans; Chromans; Clofibrate; Clofibric Acid; Epinephrine; Humans; Malondialdehyde; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thrombin | 1989 |
Beclobrinic acid--a new hypolipidemic agent--inhibits in vitro human platelet activation by blocking prostaglandin synthesis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Benzhydryl Compounds; Blood Platelets; Clofibrate; Clofibric Acid; Humans; Hypolipidemic Agents; In Vitro Techniques; Malondialdehyde; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Serotonin | 1985 |
Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Blood Platelets; Calcium; Cyclic AMP; Fibrinogen; Humans; L-Lactate Dehydrogenase; Magnesium; Malondialdehyde; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane B2 | 1981 |
Platelet function studies in coronary heart disease. IX. Increased platelet prostaglandin generation and abnormal platelet sensitivity to prostacyclin and endoperoxide analog in angina pectoris.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Angina Pectoris; Blood Platelets; Coronary Disease; Epoprostenol; Humans; Malondialdehyde; Middle Aged; Platelet Function Tests; Prostaglandin Endoperoxides, Synthetic; Prostaglandins | 1980 |
Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Catalysis; Cells, Cultured; Chromatography, Thin Layer; Cytochrome P-450 Enzyme System; Fatty Acids, Unsaturated; Heme; Humans; Malondialdehyde; Microsomes, Liver; Mutagens; Prostaglandin Endoperoxides; Prostaglandin H2; Prostaglandins H; Rabbits | 2000 |